Work

AAV Capsid Proteins Fused with SARS-CoV-2 RBD or RBM: Expression in E. coli, In-Vitro Assembly, and Characterization

Year: 2021

Type: article

Abstract: Le DT, Behrsing O, Rothschild C, Radukic M, Arndt KM, Müller K. AAV Capsid Proteins Fused with SARS-CoV-2 RBD or RBM: Expression in E. coli, In-Vitro Assembly, and Characterization. In: 24th Annual Meeting of the American Society of Gene & Cell Therapy. Complete listing of the accepted abstracts for presentation at ASGCT's 24th Annual Meeting, May 11-May 14, 2021. Molecular Therapy . Vol 29. Cambridge: Cell Press; 2021: 357.

Source: publish.UP (University of Potsdam)

DOI: 10.1016/j.ymthe.2021.04.019

Authors: Dang Thi Thanh Le, Olaf Behrsing, C. Rothschild, Marco T. Radukic, Katja M. Arndt, Kristian M. Müller

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3162975734

FWCI:

Cites:

Cited by:

Related to: 10